Robert L. Coleman, MD, FACOG, FACS, discloses the following:
Grant or Research Support: AstraZeneca, Clovis Oncology, Genentech-Roche, Janssen, Merck;
Paid Consultant: AbbVie, Cell Medica, COR2ED, Geistlich, Genmab, MoreHealth, Takeda, Tesaro;
Speaker's Bureau/Honoraria: Banner MDACC, Medscape, OncLive, Physicians Education Resource, Research to Practice, Roche, Scripps Cancer Center, Targeted Oncology;
Membership advisory board: Aravive Biologics, Inc., ArQule, AstraZeneca, Clovis Oncology, Cordgenics, Eisai Medical Research, Genentech, Inc., ImmunoGen, Merck, Mersana Therapeutics, Inc., Myriad, National Comprehensive Cancer Network, Novocure, OncoMed Pharmaceuticals, Inc., Tesaro.
The following Faculty/Program Planning Committee Members and CME Activity Reviewers/Approvers HAVE INDICATED THEY HAVE NO FINANCIAL INTERESTS, arrangements or affiliations with the manufacturer of any product or devices to be discussed, or who may financial support this CME activity. An asterisk (*) indicates that the faculty’s presentation will include discussion of investigational or off-label uses of a product.
Planning Committee Members
Mary Gabb, Tamara Greiner, Daniel Guinee
CME Activity Reviewers/Approvers
Diane C. Bodurka, MD, BS, MPH (approver); Jack Fu, MD; Peter Norman, MD; Brian R. Weston, MD